Which Should You Buy: Valeant Pharmaceuticals Intl Inc. or Home Capital Group Inc.?

Home Capital Group Inc. (TSX:HCG) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have seen their stock prices fall this year. Can either company recover?

| More on:

Stocks that have seen prices decline as a result of scandals and problems present buying opportunities for investors that are not risk averse. The danger in investing in a company that is in turmoil is that the stock could continue to plummet with no end in sight. The easiest example is Sears Canada Inc., which is now in the process of liquidation; months ago, it might have been seen as a bargain opportunity if it could turn things around.

But if is a dangerous word, and just because a stock has declined is not a reason to invest. Instead, it is important, once you find these “bargain” stocks, to look at the company’s financials and assess its long-term prospects. If a company is heavy on debt, sales are declining, and there doesn’t look to be light at the end of the tunnel, it’s best to stay away from the free-falling stock. However, a company ridden by scandals or bad press but has good financials and a promising future might present a good long-term opportunity, as long as you can stomach the fluctuations in the process.

I’ll look at two companies’ stocks that have taken a beating and could present strong long-term upside.

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has seen its stock tumble 30% in the past year, and over five years, the stock has declined by over 58%. The company was trading at over $319 a share in September 2015 when news came out about Valeant’s purchase of Addyi, the “female Viagra” pill. The problem with the purchase is, although it was FDA approved, the drug had serious health risks associated with it. Valeant purchased the maker of the high-risk drug for $1 billion, and, as a result, the stock plummeted to $100 a share and soon reached just $34.

Big risks aren’t the only items that have concerned investors. The company is heavily leveraged in debt. At the end of 2015, the company had a debt-to-equity ratio of 5.26 with debt levels reaching over $30 billion. The company was able to bring debt levels down to $29 billion, but a dropping equity resulted in the ratio rising to 9.46 for the end of 2016.

Although the company has expressed a desire to continue paying down its debt, it may be a losing battle, as the company still expects to make large investments into research and development.

Home Capital Group Inc. (TSX:HCG) is a very different case of a company that has been ridden with bad press and scandals in the past several months. The mortgage lender has been involved in fraudulent mortgage applications, and the company’s CEO was fired earlier this year amid accusations of misleading investors.

These types of scandals don’t fade from memory easily, but Berkshire Hathaway Inc. came to the rescue. Berkshire has provided Home Capital with some life support. Home Capital is a bit heavy on debt as well, but with a debt-to-equity ratio of just 1.63 for the latest year, it pales in comparison to the problem Valeant has.

With the problems and individuals associated with fraudulent activities removed from the company, a better balance sheet, and reasonable prospects for a recovery, Home Capital presents a much more attractive opportunity for investors than Valeant.

Fool contributor David Jagielski has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

woman checks off all the boxes
Dividend Stocks

TFSA Investors Take Note — The CRA Is Actively Watching for These Red Flags

Holding the iShares S&P/TSX 60 Index Fund (TSX:XIU) in your TFSA can spare you scrutiny for non-approved investments.

Read more »

Warning sign with the text "Trade war" in front of container ship
Stocks for Beginners

Worried About Tariffs? 2 TSX Stocks I’d Buy and Hold

Understand how tariffs affect major companies like Bombardier and Magna International amidst the USMCA negotiations.

Read more »

warehouse worker takes inventory in storage room
Tech Stocks

A Once-in-a-Decade Investment Opportunity: The 2 Best AI Stocks to Buy in April 2026

Kinaxis and Docebo are two Canadian AI stocks with record growth, expanding margins, and massive tailwinds. Here is why April…

Read more »

Dividend Stocks

This Monthly Paying TSX Stock Yields 8.1% and Deserves Your Attention

A strong yield and steady growth make this monthly dividend stock hard to ignore.

Read more »

Canadian dollars in a magnifying glass
Dividend Stocks

The Canadian Stocks I’d Consider Most If I Had $10,000 to Invest in 2026

If you’re planning to invest in 2026, these two TSX stocks stand out for all the right reasons.

Read more »

A woman shops in a grocery store while pushing a stroller with a child
Dividend Stocks

This 7% Dividend Stock Pays Cash Every Single Month

This dividend stock delivers a reliable 7.4% yield and steady monthly cash flow for income‑focused investors.

Read more »

ETF is short for exchange traded fund, a popular investment choice for Canadians
Dividend Stocks

A 3.5% Yielding Monthly Income ETF Every Canadian Should Review

VDY might not be the highest-yielding dividend ETF, but it ranks among the best in terms of historical total returns.

Read more »

hot air balloon in a blue sky
Dividend Stocks

The Canadian Blue-Chip Stocks I’d Use to Build Lasting Long-Term Wealth

These blue-chip stocks aren't just some of the best picks Canadians can consider; they're stocks that give you confidence to…

Read more »